Opportunistic Infections

Medical Advocates
Opportunistic Infections/Diseases

Management

General Reports
OI Drugs
HAART and OIs
OI Prophylaxis
Treatment Guidelines
Treatment Failure

OI Main Page Main New/Newsworthy Home Page

Last Update: May 06, 2017
. Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader

General Reports

           Journal Papers, Abstracts, and Commentaries

Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China.
Yang R, Zhang H, Xiong Y, et al
AIDS Res Ther. 2017 May 2
Abstract
Treatment of Opportunistic Infections Prior to HAART Initiation Does Not Affect Immune Reconstitution in HIV-Infected Patients.
Pornprasert S, Traisathit P, Singboottra P, Ngo-Giang-Huong N.
Curr HIV Res. 2012 Sep 6..
Abstract

FULL-TEXT ARTICLE
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure.
Howard SJ, Cerar D, Anderson MJ, et al
Emerg Infect Dis. 2009 Jul;15(7):1068-76
Paper

OI Drugs

Amphotericin B

               Journal Papers, Abstracts, and Commentaries

Comparison of in vitro Antifungal Activities of Amphotericin B Lipid Complex with Itraconazole against 708 Clinical Yeast Isolates and Opportunistic Moulds Determined by National Committee for Clinical Laboratory Standards Methods M27-A and M38-P.
Carrillo-Munoz AJ, Ruesga M, Brio S, Del Valle O, et al
Chemotherapy 2002 Dec;48(5):224-231
Abstract

Caspofungin

               Journal Papers, Abstracts, and Commentaries

The use of caspofungin in HIV-infected individuals.
Waters L, Nelson M.
Expert Opin Investig Drugs. 2007 Jun;16(6):899-908.
Abstract

Cotrimoxazole

               Journal Papers, Abstracts, and Commentaries

Cotrimoxazole for prophylaxis or treatment of opportunistic infections of HIV/AIDS in patients with previous history of hypersensitivity to cotrimoxazole.
Lin D, Li W, Rieder M.
Cochrane Database Syst Rev. 2007 Apr 18;(2):CD005646.
Abstract

Itraconazole

               Journal Papers, Abstracts, and Commentaries

Clinical experience with itraconazole in systemic fungal infections .
Boogaerts M, Maertens J.
Drugs 2001;61 Suppl 1:39-47
Abstract

Pentoxiphylline

               Journal Papers, Abstracts, and Commentaries

Prevention of opportunistic infections in HIV infection by pentoxiphylline.
Wanchu A, Bhatnagar A, Bambery P, et al
Indian J Med Res. 2006 Dec;124(6):705-8
Abstract

HAART and OIs

        Journal Papers, Abstracts, and Commentaries

Response to HAART in Treatment-Naive HIV-Infected Patients with a Prior Diagnosis of Tuberculosis or other Opportunistic Infections.
Dronda F, Sobrino P, Hern�ndez-Novoa B, et al
Curr HIV Res. 2011 Jun 2.
Abstract
Early Antiretroviral Therapy for Patients With Acute AIDS-Related Opportunistic Infections: A Cost-Effectiveness Analysis of ACTG A5164.
Sax PE, Sloan CE, Schackman BR, et al
HIV Clin Trials. 2010 Jan 1;11(5):248-259.
Abstract

Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in Patients with HIV Previously Receiving Episodic Therapy: A Randomized Trial.
The SMART Study Group.
Ann Intern Med. 2008 Sep 2;149(5):289-299.
Abstract

Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy.
Kirk O, Reiss P, Uberti-Foppa C, Bickel M, et al.
Ann Intern Med 2002 Aug 20;137(4):239-50
Abstract

OI Prophylaxis

General Reports

        Journal Papers, Abstracts, and Commentaries

Evaluation of the current management protocols for prophylaxis against Pneumocystis jiroveci pneumonia and other opportunistic infections in patients living with HIV/AIDS.
Jain SB, Wig N, Nagpal SJ, et al
AIDS Care. 2011 Mar 9:1-5.
Abstract
Effect of prophylaxis on the clinical manifestations of AIDS-related opportunistic infections.
Sepkowitz KA.
Clin Infect Dis 1998 Apr;26(4):806-10
Abstract

Resource-Affluent Countries Issues

Spain

        Journal Papers, Abstracts, and Commentaries

Prevention of opportunistic infections in adult and adolescent patients with HIV infection. GESIDA/National AIDS Plan guidelines, 2003.
Berenguer J, Laguna F, Lopez-Aldeguer J, et al.
Enferm Infecc Microbiol Clin. 2004 Mar;22(3):160-76.
Abstract

United States

        Journal Papers, Abstracts, and Commentaries

Prophylaxis of opportunistic infections.
Tantisiriwat W, Powderly WG.
Infect Dis Clin North Am 2000 Dec;14(4):929-44
Abstract

Resource-Limited Countries Issues

India
        Journal Papers, Abstracts, and Commentaries

Prevention of opportunistic infections in HIV infection by pentoxiphylline.
Wanchu A, Bhatnagar A, Bambery P, et al
Indian J Med Res. 2006 Dec;124(6):705-8
Abstract

West Africa

        Journal Papers, Abstracts, and Commentaries

Prevention of wasting and opportunistic infections in HIV-infected patients in West Africa: a realistic and necessary strategy before antiretroviral treatment.
Ledru e, Sanou PT,Dembele M, Dahourou H, Zoubga A, Durand G.
Sante. 1999 Sep-Oct;9(5):293-300.
Abstract

Treatment/Prevention Guidelines

United States

United States

           Journal Papers, Abstracts, and Commentaries

What's New in the 2009 US Guidelines for Prevention and Treatment of Opportunistic Infections Among Adults and Adolescents with HIV?
Brooks JT, Kaplan JE, Masur H.
Top HIV Med. 2009 Jul-Aug;17(3):109-14
Abstract

A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT DOCUMENT
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
CDC, NIH, and HIV Medicine Association of the IDSA
MMWR April 10, 2009
Paper

Treatment Failure

           Journal Papers, Abstracts, and Commentaries

FULL-TEXT ARTICLE
Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with
treatment failure.
Howard SJ, Cerar D, Anderson MJ, et al
Emerg Infect Dis. 2009 Jul;15(7):1068-76
Paper

OI Main Page Main New/Newsworthy Home Page

HIV Opportunistic Infections/Diseases
Management